Auricular Acupuncture in the Treatment of Obesity
NCT02269371 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82
Last updated 2024-08-06
Summary
Male and female DoD beneficiaries ages 18 years or older, who are referred for a standard of care weight loss intervention for treatment of obesity will be recruited. Subjects will be randomized into one of two groups receiving either a standard of care weight loss intervention plus auricular acupuncture at Shen Men, Point Zero, and Appetite Control Point/Hunger Point or receiving a standard of care weight loss intervention plus sham auricular acupuncture. Subjects will receive treatment in accordance with their randomization group for 12 weeks then have one additional follow up visit at week 24. The following measures will be obtained: height, weight, waist circumference, and Body Mass Index will be calculated.
Conditions
Interventions
- OTHER
-
Auricular Acupuncture
Standard of care weight loss intervention plus auricular acupuncture at Shen Men, Point Zero, and Appetite Control Point/Hunger Point in each ear.
- OTHER
-
Sham Acupuncture
Standard of care weight loss intervention plus sham acupuncture at three nonacupoints in each ear.
Sponsors & Collaborators
-
Mike O'Callaghan Military Hospital
lead FED
Principal Investigators
-
Clinton Borchardt, MD · Mike O'Callaghan Federal Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-02-28
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity
NCT04010786 ·Status: COMPLETED ·Phase: PHASE1
-
Comparing a Virtual vs. Face to Face Weight Management Program Using Phentermine for Patients With Overweight or Obesity
NCT04614545 ·Status: COMPLETED ·Phase: PHASE4
-
A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity
NCT06577766 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
NCT03548935 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study of How NNC0174-0833 Behaves in Japanese and Caucasian Volunteers Who Are Normal Weight, Overweight or With Obesity
NCT03787225 ·Status: COMPLETED ·Phase: PHASE1
-
This Study Will Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MET097 in Adult Participants With Overweight or Obesity
NCT06857617 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese
NCT03574584 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight
NCT04667377 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain Activity
NCT06352424 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults
NCT05786521 ·Status: COMPLETED ·Phase: PHASE4
-
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
NCT04822181 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers
NCT01044108 ·Status: TERMINATED ·Phase: PHASE1
-
A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity
NCT02835235 ·Status: COMPLETED ·Phase: PHASE1
-
Deoxycholic Acid Injection Submental Fat (SMF) Magnetic Resonance Imaging (MRI) and Subject-reported Outcome Measures Study
NCT01032889 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or Obesity
NCT06478563 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of a Supplement for Weight Management in Obese and Overweight Individuals
NCT03812211 ·Status: COMPLETED ·Phase: NA
-
Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)
NCT00533481 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906
NCT05751226 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Multiple Doses of ZGN-433 in Obese Female Volunteers
NCT01028261 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous Presentations
NCT07313761 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Phase 2 Trials of NA-931 to Study Subjects Who Are Obese With at Least One Weight-related Comorbid Condition
NCT06564753 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or Obese
NCT03707990 ·Status: COMPLETED ·Phase: PHASE1
-
Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants
NCT07223216 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesity
NCT03842202 ·Status: COMPLETED ·Phase: PHASE1
-
EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial
NCT04531176 ·Status: TERMINATED ·Phase: PHASE4